Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
VNRX 
Volitionrx Ltd (VNRX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/12/2025: VNRX (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
6 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $2.6
1 Year Target Price $2.6
| 3 | Strong Buy |
| 2 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -20.02% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/12/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 33.03M USD | Price to earnings Ratio - | 1Y Target Price 2.6 |
Price to earnings Ratio - | 1Y Target Price 2.6 | ||
Volume (30-day avg) 6 | Beta 1.26 | 52 Weeks Range 0.27 - 0.94 | Updated Date 12/14/2025 |
52 Weeks Range 0.27 - 0.94 | Updated Date 12/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.23 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -813.2% |
Management Effectiveness
Return on Assets (TTM) -148.34% | Return on Equity (TTM) -730.06% |
Valuation
Trailing PE - | Forward PE 20.83 | Enterprise Value 44092770 | Price to Sales(TTM) 22.44 |
Enterprise Value 44092770 | Price to Sales(TTM) 22.44 | ||
Enterprise Value to Revenue 29.95 | Enterprise Value to EBITDA -1.43 | Shares Outstanding 122801572 | Shares Floating 91594009 |
Shares Outstanding 122801572 | Shares Floating 91594009 | ||
Percent Insiders 15.83 | Percent Institutions 21.27 |
About Volitionrx Ltd
Exchange NYSE MKT | Headquaters Henderson, NV, United States | ||
IPO Launch date 2007-04-25 | Founder, CEO, President & Director Mr. Cameron Reynolds MBA | ||
Sector Healthcare | Industry Medical Devices | Full time employees 75 | Website https://volition.com |
Full time employees 75 | Website https://volition.com | ||
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes; Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is based in Henderson, Nevada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.